Enrollment Begins for Trial Evaluating SPI-1005 for Meniere’s Disease
According to a news release from biotechnology company Sound Pharmaceuticals, enrollment has begun in the Phase 3 STOPMD-3 clinical trial. So far, the first patient has been enrolled – with…